UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Journal of hematology and oncology, 2021-05, Vol.14 (1), p.1-82, Article 82

2021

Volltextzugriff (PDF)

Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1710-1713

2021

Volltextzugriff (PDF)

Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1674-1682

2021

Volltextzugriff (PDF)

A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Coexistence of the JAK2V617F Clone

Turkish journal of haematology, 2024-05, Vol.41 (2), p.123-125

2024

Volltextzugriff (PDF)

Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2020-06, Vol.55 (6), p.1206-1208

2020

Volltextzugriff (PDF)

Bacterioplankton assemblages as biological indicators of shrimp health status

Ecological indicators, 2014-03, Vol.38, p.218-224

2014

Volltextzugriff (PDF)

EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia

PloS one, 2013-04, Vol.8 (4), p.e61341

2013

Volltextzugriff (PDF)

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes

Experimental hematology & oncology, 2020-06, Vol.9 (1), p.11-11, Article 11

2020

Volltextzugriff (PDF)

Orthogonal experiments and bonding analysis of ultrasonic welded multi-layer battery foils and tabs

Engineering science and technology, an international journal, 2024-07, Vol.55, p.101748, Article 101748

2024

Volltextzugriff (PDF)

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

Journal of hematology and oncology, 2018-08, Vol.11 (1), p.103-103, Article 103

2018

Volltextzugriff (PDF)

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Frontiers in oncology, 2021-05, Vol.11, p.664421-664421

2021

Volltextzugriff (PDF)

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase

Frontiers in immunology, 2022-11, Vol.13, p.1012981

2022

Volltextzugriff (PDF)

FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation

International journal of hematology, 2017-10, Vol.106 (4), p.552-561

2017

Volltextzugriff (PDF)

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells

Bone marrow transplantation (Basingstoke), 2019-07, Vol.54 (7), p.1138-1140

2019

Volltextzugriff (PDF)

Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial

Journal of hematology and oncology, 2024-09, Vol.17 (1), p.79-5, Article 79

2024

Volltextzugriff (PDF)

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia

Experimental hematology & oncology, 2022-09, Vol.11 (1), p.1-67, Article 67

2022

Volltextzugriff (PDF)

Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy

Frontiers in immunology, 2022-03, Vol.13, p.858590-858590

2022

Volltextzugriff (PDF)

Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria

Frontiers in medicine, 2022-04, Vol.9, p.854338

2022

Volltextzugriff (PDF)

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

Experimental hematology & oncology, 2023-04, Vol.12 (1), p.36-36, Article 36

2023

Volltextzugriff (PDF)

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.60-60, Article 60

2023

Volltextzugriff (PDF)

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma

Biomarker research, 2020-05, Vol.8 (1), p.14-14, Article 14

2020

Volltextzugriff (PDF)

Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines

PloS one, 2015-11, Vol.10 (11), p.e0139663-e0139663

2015

Volltextzugriff (PDF)

P518: VENETOCLAX AND AZACITIDINE COMBINED WITH CHIDAMIDE (VAC) FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MONOCYTIC LEUKEMIA PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e204697f-n/a

2023

Volltextzugriff (PDF)

Venetoclax Combined with Hypomethylation Agents As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia - Priliminary Results from a Real World Study in China

Blood, 2023-11, Vol.142 (Supplement 1), p.1518-1518

2023

Volltextzugriff (PDF)

Anti CD19 CART Therapy Following Allogenic Hematopoietic Stem Cell Transplantation Improved the Survival of Patients with BCR::ABL1-like Acute Lymphoblastic Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.10345-10346

2022

Volltextzugriff (PDF)

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(312)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(232)
Life Sciences & Biomedicine
(114)
Technology
(83)
Physical Sciences
(73)
Humans
(54)
Materials Science
(50)
Chemistry
(48)
Materials Science, Multidisciplinary
(44)
Science & Technology - Other Topics
(44)
Female
(34)
Oncology
(34)
Male
(29)
Chemistry, Physical
(26)
Animals
(25)
Chemistry, Multidisciplinary
(24)
Engineering
(24)
Hematology
(24)
Physics
(22)
Nanoscience & Nanotechnology
(21)
Multidisciplinary Sciences
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations

Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation

A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Coexistence of the JAK2V617F Clone

Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia

Bacterioplankton assemblages as biological indicators of shrimp health status

EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes

Orthogonal experiments and bonding analysis of ultrasonic welded multi-layer battery foils and tabs

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase

FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells

Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia

Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy

Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma

Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines

P518: VENETOCLAX AND AZACITIDINE COMBINED WITH CHIDAMIDE (VAC) FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MONOCYTIC LEUKEMIA PATIENTS

Venetoclax Combined with Hypomethylation Agents As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia - Priliminary Results from a Real World Study in China

Anti CD19 CART Therapy Following Allogenic Hematopoietic Stem Cell Transplantation Improved the Survival of Patients with BCR::ABL1-like Acute Lymphoblastic Leukemia

Suchergebnisse filtern